Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-18 | Mr. Caracciolo received a B.S. degree in Pharmaceutical Science from St. John’s University in 1978. |
| 2015-01-23 | Anthony D. Caracciolo - Director, received stock options and cash fees, no mention of technical or software skills. |
| 2015-07-17 | Mr. Caracciolo received a B.S. degree in Pharmaceutical Science from St. Johns University in 1978. |
| 2016-02-18 | The following table sets forth certain information regarding the compensation earned by or awarded to each non-employee director for services during fiscal 2015... Anthony D. Caracciolo... No mention of technical or software skills. |
| 2016-07-20 | Mr. Caracciolo has over 30 years of experience in the pharmaceutical sciences industry... Mr. Caracciolo received a B.S. degree in Pharmaceutical Science from St. John’s University in 1978. |
| 2017-07-24 | Mr. Caracciolo has over 30 years of experience in the pharmaceutical sciences industry. He was formerly employed at Gilead Sciences, Inc., a publicly held, research-based biopharmaceutical company... Mr. Caracciolo brings to the Board an understanding of the Company’s operational issues and extensive experience in management and the biotech industry. |
| 2018-10-15 | Mr. Caracciolo has over 30 years of experience in the pharmaceutical sciences industry. He was formerly employed at Gilead Sciences, Inc., a publicly held, research-based biopharmaceutical company... Mr. Caracciolo brings to the Board an understanding of the Company’s operational issues and extensive experience in management and the biotech industry. |
| 2019-04-22 | Mr. Caracciolo, in his capacity as Executive Chairman, was an employee during the fiscal year ended May 31, 2018 ... Effective July 11, 2018, Mr. Caracciolo resigned as Executive Chairman of the Board, and continued to serve as the Non-Executive Chairman of the Board until his resignation on January 10, 2019. |
Data sourced from SEC filings. Last updated: 2026-02-03